What Analysts Think of Eli Lilly Stock Ahead of Earnings

1. Eli Lilly to report earnings, analysts expect increased sales and profit. 2. Analysts remain bullish, predicting revenue of $13.63 billion, up 45% YoY. 3. Weight-loss drugs are key revenue drivers with production set to rise significantly. 4. 10 out of 11 analysts rate LLY as 'buy' with 21% upside on average. 5. Eli Lilly previously lowered sales forecasts, but eyes strong Q4 performance.